8 Stocks Under $5 Seeing Institutional And Insider Buying

Here we present a list of eight stocks trading under $5 that have seen net institutional and insider buying over the current quarter and past six months, respectively.

Hedge funds and insiders seem to think these companies offer good value at current levels–what do you think? 

Interactive chart: Click play to see changes in return over two years

Use this list as a starting point for your own analysis.  Read  descriptions for all companies mentioned.

1. Lexicon Pharmaceuticals, Inc. ( LXRX): Focuses on the discovery and development of drug candidates for the treatment of various human diseases. Market cap at $1.11B, most recent closing price at $2.16.

Net institutional purchases in the current quarter at 13.8M shares, which represents about 6.07% of the company's float of 227.31M shares.

Over the last six months, insiders were net buyers of 3,000,000 shares, which represents about 1.32% of the company's 227.31M share float.

2. Mattersight Corporation ( MATR): Provides enterprise analytics managed services. Market cap at $74.72M, most recent closing price at $4.39.

Net institutional purchases in the current quarter at 341.6K shares, which represents about 5.86% of the company's float of 5.83M shares.

Over the last six months, insiders were net buyers of 453,091 shares, which represents about 7.77% of the company's 5.83M share float.

3. MannKind Corp. ( MNKD): Focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. Market cap at $1.02B, most recent closing price at $3.54.

Net institutional purchases in the current quarter at 13.2M shares, which represents about 8.67% of the company's float of 152.29M shares.

Over the last six months, insiders were net buyers of 39,997,650 shares, which represents about 26.26% of the company's 152.29M share float.

4. Pacific Biosciences of California, Inc. ( PACB): Develops, manufactures, and markets an integrated platform for genetic analysis. Market cap at $134.55M, most recent closing price at $2.34.

Net institutional purchases in the current quarter at 3.1M shares, which represents about 9.08% of the company's float of 34.15M shares.

Over the last six months, insiders were net buyers of 1,400,000 shares, which represents about 4.1% of the company's 34.15M share float.

5. TheStreet, Inc. ( TST): Operates as a digital financial media company in the United States. Market cap at $63.92M, most recent closing price at $1.92.

Net institutional purchases in the current quarter at 2.0M shares, which represents about 10.22% of the company's float of 19.57M shares.

Over the last six months, insiders were net buyers of 472,600 shares, which represents about 2.41% of the company's 19.57M share float.

6. Vitesse Semiconductor Corp. ( VTSS): Engages in the design, development, manufacture, and marketing of semiconductor products to original equipment manufacturers (OEMs) of carrier and enterprise networking products, and data center infrastructure systems worldwide. Market cap at $79.6M, most recent closing price at $2.13.

Net institutional purchases in the current quarter at 10.9M shares, which represents about 44.62% of the company's float of 24.43M shares.

Over the last six months, insiders were net buyers of 3,363,150 shares, which represents about 13.77% of the company's 24.43M share float.

7. MEMC Electronic Materials Inc. ( WFR): Engages in the development, manufacture, and sale of silicon wafers for the semiconductor industry worldwide. Market cap at $985.47M, most recent closing price at $4.26.

Net institutional purchases in the current quarter at 9.9M shares, which represents about 5.08% of the company's float of 194.74M shares.

Over the last six months, insiders were net buyers of 3,328,680 shares, which represents about 1.71% of the company's 194.74M share float.

8. XOMA Corporation ( XOMA): Engages in the discovery, development, and manufacture of therapeutic antibodies to treat inflammatory, autoimmune, infectious, and oncological diseases. Market cap at $275.89M, most recent closing price at $3.33.

Net institutional purchases in the current quarter at 9.9M shares, which represents about 20.45% of the company's float of 48.41M shares.

Over the last six months, insiders were net buyers of 4,722,670 shares, which represents about 9.76% of the company's 48.41M share float.
 

List compiled by Rebecca Lipman, Kapitall Editor. Institutional data sourced from Fidelity, insider data from Yahoo! Finance, all other data sourced from Finviz.

null

If you liked this article you might like

Biotech Mailbag: Buy Dip in T2 Biosystems?

Biotech Mailbag: Buy Dip in T2 Biosystems?

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

4 Smaller Biotech Names Worth Researching

4 Smaller Biotech Names Worth Researching

7 Things to Watch in Biotech Now

7 Things to Watch in Biotech Now

These 3 Biotech Stocks Are Already Moving Wildly on Thursday

These 3 Biotech Stocks Are Already Moving Wildly on Thursday